Patents by Inventor Martin Himly

Martin Himly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11598765
    Abstract: The present invention relates to a flatbed air-liquid interface exposure module for exposing a plurality of cells at an air-liquid interface to nanoparticles, the flatbed air-liquid interface exposure module comprising a moisturizing section, an exposure section, and an aerosol duct. Further provided are related systems and methods.
    Type: Grant
    Filed: November 23, 2017
    Date of Patent: March 7, 2023
    Assignees: VITO NV, Paris-Lodron-Universität Salzburg
    Inventors: Evelien Frijns, Johan Van Laer, Sandra Verstraelen, An Jacobs, Albert Duschl, Martin Himly, Pierre Madl
  • Patent number: 9040054
    Abstract: The present invention relates to a hypoallergenic molecule consisting of Bet v Ia or an allergen having at least 40% identity to Bet v Ia comprising mutations of at least four amino acid residues in the region of amino acids 100 to 125 of Bet v Ia or its corresponding region of the allergen having at least 40% identity to Bet v 1a.
    Type: Grant
    Filed: June 30, 2008
    Date of Patent: May 26, 2015
    Assignee: BIOMAY AG
    Inventors: Michael Wallner, Barbara Bohle, Martin Himly, Nicole Wopfner, Gabriele Gadermaier, Matthias Egger, Peter Lackner, Fatima Ferreira, Michael Hauser
  • Publication number: 20140242668
    Abstract: The present invention relates to a variant of a mature polysaccharide lyase having a beta helix structure, wherein said variant comprises an N- and/or C-terminal truncation and consists essentially of at least 90% of the beta helix structure of the mature polysaccharide lyase.
    Type: Application
    Filed: July 9, 2012
    Publication date: August 28, 2014
    Applicant: BIOMAY AG
    Inventors: Michael Wallner, Michael Hauser, Gabriele Gadermaier, Martin Himly, Fatima Ferreira
  • Publication number: 20110217334
    Abstract: The present invention relates to a hypoallergenic molecule consisting of Bet v Ia or an allergen having at least 40% identity to Bet v Ia comprising mutations of at least four amino acid residues in the region of amino acids 100 to 125 of Bet v Ia or its corresponding region of the allergen having at least 40% identity to Bet v Ia.
    Type: Application
    Filed: June 30, 2008
    Publication date: September 8, 2011
    Applicant: BIOMAY AG
    Inventors: Michael Wallner, Barbara Bohle, Martin Himly, Nicole Wopfner, Gabriele Gadermaier, Matthias Egger, Peter Lackner, Fatima Ferreira, Michael Hauser
  • Patent number: 6984726
    Abstract: The invention relates to DNA molecules which code for the allergen Art v 1 or isoforms thereof, the sequence of the allergen, a method for the production of an Art v 1 molecule, a vector and a transformed host cell.
    Type: Grant
    Filed: March 25, 1999
    Date of Patent: January 10, 2006
    Assignee: BIOMAY Produktions- und Handels-Aktiengesellschaft
    Inventors: Fatima Ferreira, Klaus Richter, Martin Himly, Edwin Engel, Christof Ebner, Michael Breitenbach, Dietrich Kraft